{"count": 3, "results": [{"_id": "7796449", "pmid": 7796449, "title": "Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.", "journal": "Cardiovasc Res", "authors": ["Kabour A", "Henegar JR", "Devineni VR", "Janicki JS"], "date": "1995-04-01T00:00:00Z", "meta_date_publication": "1995 Apr", "meta_volume": "29", "meta_issue": "4", "meta_pages": "543-8", "score": 50065.15, "text_hl": "Prevention of @GENE_AGT @GENE_24179 @@@angiotensin II@@@ induced myocyte @DISEASE_Necrosis @DISEASE_MESH:D009336 @@@necrosis@@@ and @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary vascular damage@@@ by @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ in the @SPECIES_10116 @@@rat@@@.", "citations": {"NLM": "Kabour A, Henegar JR, Devineni VR, Janicki JS. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovasc Res. 1995 Apr;29(4):543-8. PMID: 7796449", "BibTeX": "@article{7796449, title={Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.}, author={Kabour A and Henegar JR and Devineni VR and Janicki JS}, journal={Cardiovasc Res}, volume={29}, number={4}, pages={543-8}}"}}, {"_id": "7533225", "pmid": 7533225, "title": "Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.", "journal": "J Cardiovasc Pharmacol", "authors": ["Motz W", "Strauer BE"], "date": "1994-01-01T00:00:00Z", "doi": "10.1097/00005344-199424001-00007", "meta_date_publication": "1994", "meta_volume": "24 Suppl 1", "meta_issue": "", "meta_pages": "S34-8", "score": 50060.184, "text_hl": "The @GENE_ACE @GENE_24310 @@@angiotensin-converting enzyme@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ was shown to improve @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ reserve and to reserve both @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@medial hypertrophy@@@ and @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@myocardial fibrosis@@@ in SHRs. ", "citations": {"NLM": "Motz W, Strauer BE. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation. J Cardiovasc Pharmacol. 1994;24 Suppl 1():S34-8. PMID: 7533225", "BibTeX": "@article{7533225, title={Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.}, author={Motz W and Strauer BE}, journal={J Cardiovasc Pharmacol}, volume={24 Suppl 1}, pages={S34-8}}"}}, {"_id": "12635373", "pmid": 12635373, "title": "[Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy].", "journal": "Rev Med Chir Soc Med Nat Iasi", "authors": ["Ionescu SD", "Sandru V", "Leuciuc E", "Manea P", "Burdujan A", "Tovarniţchi S", "Cosovanu A"], "date": "2002-01-01T00:00:00Z", "meta_date_publication": "2002 Jan-Mar", "meta_volume": "106", "meta_issue": "1", "meta_pages": "128-31", "score": 50036.953, "text_hl": "Different generations of ACE inhibitors were used, but @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@, @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lysinopril@@@ were the most commonly administered. ", "citations": {"NLM": "Ionescu SD, Sandru V, Leuciuc E, Manea P, Burdujan A, Tovarniţchi S, Cosovanu A. [Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy]. Rev Med Chir Soc Med Nat Iasi. 2002 Jan-Mar;106(1):128-31. PMID: 12635373", "BibTeX": "@article{12635373, title={[Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy].}, author={Ionescu SD and Sandru V and Leuciuc E and Manea P and Burdujan A and Tovarniţchi S and Cosovanu A}, journal={Rev Med Chir Soc Med Nat Iasi}, volume={106}, number={1}, pages={128-31}}"}}]}